Register entry

Chugai Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
3
Active NDC listings
13
Live patents
0
Countries
1
Base
Japan
Authorisation

Registered operations

Analytical testing3Active ingredient (API) manufacture2Finished drug manufacture3
Sites

Registered establishments

3
EstablishmentAddressRegistered forFEI / DUNS
Chugai Pharma Manufacturing Co., LtdRegistrant: Chugai Pharmaceutical Co., Ltd.2500 Takayanagi, Fujieda, SZO 426-0041, Japan (JPN)Analytical testing, Finished drug manufacture3002806758716464883
Chugai Pharma Manufacturing Co., LtdRegistrant: Chugai Pharmaceutical Co., Ltd.5-5-1, UKIMA, Kita-ku, TKY 115-0051, Japan (JPN)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3004109596691033815
Chugai Pharma Manufacturing Co., LtdRegistrant: Chugai Pharmaceutical Co., Ltd.16-3 Kiyohara Kogyodanchi, Utsunomiya, TCG 321-3231, Japan (JPN)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3006942691716464891
Catalogue

Drug listings by form and route

13

13 active NDC listings: 13 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 13.

Dosage formNDCs
injection, solution6
injection, solution, concentrate3
liquid3
capsule1
RouteNDCs
Labeller name on the listingNDCs
chugai pharmaceutical co., ltd.13
Catalogue

Marketed products

13
BrandGeneric nameForm / routeNDC
-Alectinib Hydrochloridecapsule60422-211DRUG FOR FURTHER PROCESSING
-Emicizumabinjection, solution60422-260DRUG FOR FURTHER PROCESSING
-Emicizumabinjection, solution60422-270DRUG FOR FURTHER PROCESSING
-Emicizumabinjection, solution60422-280DRUG FOR FURTHER PROCESSING
-Emicizumabinjection, solution60422-290DRUG FOR FURTHER PROCESSING
-Emicizumabliquid60422-302DRUG FOR FURTHER PROCESSING
-Nemolizumabliquid60422-402DRUG FOR FURTHER PROCESSING
-Satralizumabinjection, solution60422-367DRUG FOR FURTHER PROCESSING
-Tocilizumabliquid60422-202DRUG FOR FURTHER PROCESSING
-Tocilizumabinjection, solution60422-220DRUG FOR FURTHER PROCESSING
-Tocilizumabinjection, solution, concentrate60422-230DRUG FOR FURTHER PROCESSING
-Tocilizumabinjection, solution, concentrate60422-240DRUG FOR FURTHER PROCESSING
-Tocilizumabinjection, solution, concentrate60422-250DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

1
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Chugai Pharmaceutical Co., Ltd. FDA approved?
Chugai Pharmaceutical Co., Ltd. holds 3 FDA-registered establishments in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Chugai Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Fujieda; Kita-ku; Utsunomiya. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
What drugs does Chugai Pharmaceutical Co., Ltd. make?
13 products are listed under Chugai Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as injection, solution; injection, solution, concentrate; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.